Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00666302 · ClinicalTrials.gov registry record · Phase 4
A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis
A Phase 4 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 4
- Development phase
- 413
- Enrollment target
NCT00666302 is a Phase 4 study that has completed, run by Astellas Pharma. The registered enrollment target is 413 participants.
The verdict
NCT00666302, a Phase 4 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 413 participants
- Enrollment target
Study Summary
A study to compare efficacy of Protopic Ointment to that of Elidel Cream in treating patients with Atopic Dermatitis
Interventions
- DRUG tacrolimus ointment
- DRUG pimecrolimus cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 413 participants |
| Start Date | 2002-10 |
| Est. Completion | 2003-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00666302
The ClinicalTrials.gov registry entry for NCT00666302 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 413 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which tacrolimus ointment is the first listed.
NCT00666302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00666302 about?
NCT00666302 is a clinical study titled "A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis". A study to compare efficacy of Protopic Ointment to that of Elidel Cream in treating patients with Atopic Dermatitis
What is the current status of trial NCT00666302?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 413 participants. The study started on 2002-10. Estimated completion is 2003-11.
What interventions are being tested in trial NCT00666302?
The interventions under investigation include: tacrolimus ointment (DRUG), pimecrolimus cream (DRUG).
Who is sponsoring clinical trial NCT00666302?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.